Recce PharmaceuticalsRCE 
$0.342.02%24h
2.02%24h
Global rank23275
Market cap$59.63M
Change 7d4.12%
YTD Performance-4.72%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$8.79M
Dividend yield-
Main Sector
Healthcare
Category
Recce Pharmaceuticals (RCE) Cash on Hand
RCE Cash on Hand in 2022: $1.05M
According to Recce Pharmaceuticals latest financial reports the cash on hand of RCE is $1.05M, an decrease of -86.52% to 2022. At the end of 2022 company had $7.78M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
RCE Cash on Hand History from 2019 to 2023
-
Value:-
RCE Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.05M | -86.52% |
| 2022 | $7.78M | -44.51% |
| 2021 | $14.03M | 678.21% |
| 2020 | $1.80M | 564.92% |
| 2019 | $271.06K | - |
View the Top Cash on Hand Companies 
